The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A precision medicine trial leveraging tissue and blood-based tumor genomics to optimize treatment in resected stage III and high-risk stage II colon cancer (CC) patients (pts): The SAGITTARIUS trial.
 
Clara Montagut
Consulting or Advisory Role - Biocartis; Guardant Health; Merck Serono; Sanofi/Aventis
Speakers' Bureau - Amgen; Guardant Health; Merck Serono; Roche/Genentech; Takeda
 
Stefano Tamberi
Consulting or Advisory Role - AstraZeneca; Seagen; Takeda
Speakers' Bureau - AstraZeneca
 
Francesco Leone
No Relationships to Disclose
 
Michela Libertini
Travel, Accommodations, Expenses - PharmaMar
 
Francesca Negri
No Relationships to Disclose
 
Alessandro Pastorino
Honoraria - Amgen; BeiGene; Bristol-Myers Squibb; Daiichi Sankyo; Merck; MSD; Nordic Bioscience; Pierre Fabre
Consulting or Advisory Role - Amgen; BeiGene; Bristol-Myers Squibb; Daiichi Sankyo; Merck; MSD; Nordic Bioscience; Pierre Fabre
 
Salvatore Siena
Stock and Other Ownership Interests - Guardant Health; Myriad Genetics
Consulting or Advisory Role - Agenus; AstraZeneca; Bayer; Bristol-Myers Squibb; CheckmAb; Daiichi Sankyo; GlaxoSmithKline; Merck; MSD Oncology; Novartis; Pierre Fabre; Pierre Fabre; Seagen; T-One Therapeutics
Research Funding - MSD Oncology (Inst)
Patents, Royalties, Other Intellectual Property - Amgen
Travel, Accommodations, Expenses - Amgen; Bayer; Roche
 
Elisabetta Fenocchio
Consulting or Advisory Role - Merck Serono; Takeda
Travel, Accommodations, Expenses - Pierre Fabre
 
Alessandra Gennari
Honoraria - Daiichi Sankyo Europe GmbH; Eisai Europe; Gilead Sciences; Lilly; Novartis; Roche
Speakers' Bureau - Eisai Europe
 
Mario Mandala
Honoraria - Bristol-Myers Squibb/Sanofi; LEO Pharma; MSD Oncology; Novartis; Pierre Fabre; Regeneron; Sanofi/Aventis
Consulting or Advisory Role - Bristol-Myers Squibb; LEO Pharma; MSD Oncology; Novartis; Pierre Fabre; Regeneron
Research Funding - Novartis (Inst)
 
Armando Santoro
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; Gilead Sciences; Incyte; MSD; Pfizer; Sanofi; SERVIER
Speakers' Bureau - Abbvie; Amgen; ArQule; AstraZeneca; Bayer; BeiGene; BMS; Celgene; Eisai; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Roche; Sandoz; Servier; Takeda
 
Noelia Tarazona
Consulting or Advisory Role - Grifols; Guardant Health; Merck Senoro; SERVIER
Research Funding - NATERA (Inst)
Travel, Accommodations, Expenses - Merck Serono; SERVIER
 
Elena Elez
Honoraria - Amgen; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Cure Teq AG; Janssen; Lilly; Medscape; Merck; Merck Serono; MSD; Novartis; Pfizer; Pierre Fabre; Repare Therapeutics; RIN Institute Inc.; Roche; Sanofi/Aventis; Seagan; SERVIER; Takeda
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Bristol Myers Squibb; Cure Teq AG; Janssen; Merck; Merck Serono; MSD; Novartis; Pfizer; Pierre Fabre; Repare Therapeutics Inc.; RIN Institute Inc.; Roche; Roche; Sanofi; Seagen; SERVIER; Takeda
Research Funding - Abbvie (Inst); Amgen (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Bayer (Inst); BeiGene (Inst); Bioncotech (Inst); Biontech Rna Pharmaceuticals GMBH (Inst); Biontech Small Molecules GMBH (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim Spain (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Daiichi Sankyo Inc. (Inst); Debiopharm Group (Inst); Genentech (Inst); Gercor (Inst); HalioDx (Inst); Hoffmann-La-Roche Ltd. (Inst); Hutchison MediPharma (Inst); Hutchison MediPharma (Inst); Iovance Biotherapeutics (Inst); Janssen Research & Development (Inst); Janssen-Cilag SA (Inst); MedImmune (Inst); Menarini (Inst); Menarini (Inst); Merck (Inst); Merck Sharp&Dohme de España SA (Inst); Merus NV (Inst); Mirati Therapeutics (Inst); Nouscom SRL. (Inst); Novartis (Inst); Novartis Farmacéutica SA (Inst); Pfizer (Inst); PharmaMar (Inst); Pierre Fabre (Inst); PledPharma (Inst); Redx Pharma (Inst); Roche (Inst); Sanofi (Inst); Scandion Oncology (Inst); Seagen (Inst); SERVIER (Inst); Sotio (Inst); Taiho Pharma USA (Inst); Taiho Pharmaceutical (Inst); WntResearch (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Cure Teq AG; Janssen; Lilly; Medscape; Merck; Merck Serono; MSD; Novartis; Pfizer; Pierre fabre; Repare Therapeutics; RIN Institute Inc.; Roche; Sanofi; Seagan; SERVIER; Takeda
 
Andrea Sartore-Bianchi
Honoraria - Pierre Fabre
Consulting or Advisory Role - Pierre Fabre; Takeda
Travel, Accommodations, Expenses - Amgen; Pierre Fabre
 
Sebastian Stintzing
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb GmbH; Daiichi Sankyo Europe GmbH; Merck KGaA; MSD; Nordic Bioscience; Pfizer; Pierre Fabre; Roche; SERVIER
Consulting or Advisory Role - Amgen; AstraZeneca; CV6 Therapeutics; Daiichi Sankyo Europe GmbH; GlaxoSmithKline; Isofol Medical; Merck KGaA; MSD; Nordic Bioscience; Pierre Fabre; Roche; Seagen; SERVIER; TERUMO
Research Funding - Amgen (Inst); Merck Serono (Inst); MSD (Inst); Pierre Fabre (Inst); Roche Molecular Diagnostics (Inst)
Patents, Royalties, Other Intellectual Property - Servier (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bayer; Lilly; Merck KGaA; Pierre Fabre; Roche; Sanofi; Sirtex Medical; Takeda
 
Susana Muñoz
No Relationships to Disclose
 
Annarita Sibilio
Employment - MedSIR (I)
 
Ylenia Silvestri
No Relationships to Disclose
 
Luca Lazzari
No Relationships to Disclose
 
Silvia Marsoni
Consulting or Advisory Role - Axiom Healthcare Strategies; Ellipses Pharma